Bone Scan Index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients

被引：0
|
作者：
Rasmussen, J. [1 ]
Poulsen, M. [2 ]
Johansen, A. [1 ]
Lund, L. [2 ]
Hoilund-Carlsen, P. [1 ]
Gerke, O. [1 ,3 ]
Edenbrandt, L. [4 ]
机构：
[1] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense, Denmark
[2] Odense Univ Hosp, Dept Urol, DK-5000 Odense, Denmark
[3] Univ Southern Denmark, Dept Econ & Business, Odense, Denmark
[4] Lund Univ, Nucl Med Unit, Skane Univ Hosp, Malmo, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [31] Editorial Comment to Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer
    Sakamoto, Shinichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (09) : 674 - 674
  • [32] Zoledronic Acid Improves Clinical Outcomes in Patients with Bone Metastatic Hormone-naive Prostate Cancer in a Multicenter Clinical Trial
    Okegawa, Takatsugu
    Higaki, Masao
    Matsumoto, Tetsuo
    Kase, Hiroshi
    Murata, Akihiro
    Noda, Kenjiro
    Noda, Haruhisa
    Asaoka, Hiroshi
    Oshi, Masaya
    Tomoishi, Junzo
    Uchida, Hiroji
    Higashihara, Eiji
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (08) : 4415 - 4420
  • [33] Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study
    Zacho, Helle D.
    Gade, Michael
    Mortensen, Jesper C.
    Bertelsen, Henrik
    Boldsen, Soren K.
    Barsi, Tamas
    Petersen, Lars J.
    UROLOGY, 2017, 108 : 135 - 140
  • [34] Bone alkaline phosphatase is predictive of prostate cancer-related outcome in metastatic hormone-refractory prostate cancer
    Lipton, A.
    Nelson, J.
    Isaacson, J.
    Hulting, S.
    Sleep, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 247 - 247
  • [35] Liver uptake on bone scan for prostate cancer metastatic workup
    Mukendi, Alain Mwamba
    CLINICAL CASE REPORTS, 2019, 7 (09): : 1819 - 1820
  • [36] Circulating tumor cell in hormone-naive metastatic prostate cancer
    Kanayama, M.
    Nagaya, N.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Medical treatment of patients with hormone-naive metastatic prostate cancer: what's new?
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 192 - 192
  • [38] Prognostic value of bone scan index as an imaging biomarker in metastatic prostate cancer: a meta-analysis
    Li, Dongyang
    Lv, Hang
    Hao, Xuanyu
    Dong, Yudi
    Dai, Huixu
    Song, Yongsheng
    ONCOTARGET, 2017, 8 (48) : 84449 - 84458
  • [39] Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naive Prostate Cancer Patients
    Sasaki, Takeshi
    Takahashi, Toshifumi
    Sekito, Sho
    Kanda, Hideki
    Higashi, Shinichiro
    Masui, Satoru
    Kojima, Takahiro
    Matsuura, Hiroshi
    Nishikawa, Kouhei
    Akamatsu, Shusuke
    Okugawa, Yoshinaga
    Kobayashi, Takashi
    Inoue, Takahiro
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : E474 - E484
  • [40] Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
    Dennis, Elizabeth R.
    Jia, Xiaoyu
    Mezheritskiy, Irina S.
    Stephenson, Ryan D.
    Schoder, Heiko
    Fox, Josef J.
    Heller, Glenn
    Scher, Howard I.
    Larson, Steven M.
    Morris, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 519 - 524
12345